跳至主要内容
临床试验/NCT01998217
NCT01998217已完成4 期

Combination of Remifentanil and Flurbiprofen in Sedation and Analgesia for ESWL of Pancreatic Stone

Changhai Hospital1 个研究点 分布在 1 个国家目标入组 60 人开始时间: 2012年9月最近更新:
适应症
干预措施
相关药物

试验速览

阶段
4 期
状态
已完成
入组人数
60
试验地点
1
主要终点
Visual analogue score of pain

研究概览

简要总结

Extracorporeal shock wave lithotripsy (ESWL) of pancreatic stones has been described as an effective approach for stone drainage and pain relief, and general or epidural anesthesia has been reported for such procedure. Single infusion of remifentanil has been described in ESWL of urinary stones, but it has never been described in ESWL of pancreatic stones. Moreover, single infusion of remifentanil might induce several complications, such as postoperative nausea and vomiting. The investigators attended to investigated whether combination of flurbiprofen with remifentanil reduced remifentanil dose and attenuated the complications.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
None

入排标准

年龄范围
18 Years 至 65 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • aged 18-65 years
  • ESWL indication was met

排除标准

  • patients with hypertension
  • patients compromised in cardiopulmonary function
  • patients undergoing ESWL for the second or more times

研究组 & 干预措施

Flur group

Experimental

Patients in this group receive both infusion of flurbiprofen and remifentanil

干预措施: Flurbiprofen and remifentanil (Drug)

Rem group

Active Comparator

Patients in this group receive single infusion of remifentanil with target concentration infusion.

干预措施: Remifentanil (Drug)

结局指标

主要结局

Visual analogue score of pain

时间窗: During ESWL procedure

次要结局

  • Cardiovascular responses including blood pressure and heart rate(During ESWL procedure)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Jia-feng Wang

M.D.

Changhai Hospital

研究点 (1)

Loading locations...

相似试验